Bionano Genomics, Inc. — Director's Dealing 2018

Aug 21, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-21

Reporting Person: DOMAIN ASSOCIATES (10% Owner)
Reporting Person: BLAIR JAMES C (10% Owner)
Reporting Person: DOVEY BRIAN H (10% Owner)
Reporting Person: VITULLO NICOLE (10% Owner)
Reporting Person: Halak Brian K (10% Owner)
Reporting Person: Kamdar Kim P. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	140	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$64.20	2019-05-10	Common Stock (227)		Direct
Stock Option (Right to Buy)	$1.28	2019-05-10	Common Stock (4928)		Direct

Footnotes

F1: The securities reported as directly beneficially owned by the designated Reporting Person may be deemed to be indirectly beneficially owned by each of the Reporting Owners listed below, each of whom is a managing member of the designated Reporting Person. Pursuant to Instruction 5(b)(iv) of Form 3, each such individual has elected to report as indirectly beneficially owned the entire number of securities owned by the designated Reporting Person, however each of them disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his or her pecuniary interest therein and/or that are not actually distributed to him or her.

F2: The stock options are held by Brian K. Halak and are fully vested. Pursuant to the limited liability company agreement of Domain Associates, LLC, upon exercise 50% of the shares issued will be transferred to Domain Associates, LLC.